Background Placental anomalies (placenta praevia, placental abruption, morbidly adherent placenta and cord insertion anomalies) are associated with maternal and fetal morbidity and mortality. It has been suggested these might be more prevalent in pregnancies after assisted reproduction technology (ART).
Introduction
Assisted reproduction technologies (ART) are increasingly being used to treat infertility worldwide. It is estimated that >1.8 million ART cycles were undertaken globally in 2010, and that more than 6.5 million children have been conceived over the past three decades. 1, 2 Since ART involves the application of novel technologies in the creation of embryos, there has always been a strong interest in assessing and quantifying the potential risks with which it is associated.
Large observational studies identified that ART pregnancies are associated with a significant risk of complications as compared with pregnancies after spontaneous conception (SC). These complications include preterm delivery, low birthweight, intrauterine growth restriction, gestational diabetes, pre-eclampsia, fetal loss and placental anomalies. 3 Although initially it was believed that these complications were more prevalent after ART due to the high incidence of multiple pregnancies, a high risk of these complications was also demonstrated in ART singleton pregnancies. [4] [5] [6] Placental anomalies (placenta praevia, placental abruption, morbidly adherent placenta and cord insertion anomalies) are a significant concern. They contribute to a range of maternal and fetal morbidities during pregnancy with potentially catastrophic outcomes. These include preterm birth, low birthweight, neonatal morbidity and mortality, haemorrhage, hysterectomy, thromboembolism, adult respiratory distress, renal failure and female mortality. [7] [8] [9] Although there are a number of studies reporting a significantly increased risk of placental anomalies after ART, this finding is not universal. 10, 11 Moreover, it is not clear whether placental anomalies are associated with the ART per se or with the characteristics of the underlying population (i.e. subfertility).
In the last 2 years there have been a substantial number of published studies that evaluate the association of placental anomalies with ART pregnancies. 3, [12] [13] [14] Considering the marked increase in published data, a systematic appraisal of the available evidence was considered essential in order to confidently evaluate this proposed higher risk of placental anomalies after ART.
This systematic review will focus on answering the question of whether singleton pregnancies after ART are associated with a higher risk of placental anomalies compared with non-ART pregnancies. Furthermore, whether this risk is associated with ART treatment per se or with the characteristics of the patients seeking fertility treatment, will be explored.
Methods

Identification of studies
A computerised literature search in MEDLINE, EMBASE, CENTRAL, Scopus and Web of Science covering up to January 2018 was performed by two appraisers (B.G.V and A.B.) independently for validity and content. The aim was to identify comparative cohort studies that provided data on placental anomalies (i.e. placenta praevia, placental abruption, morbidly adherent placenta and cord insertion anomalies) in ART and non-ART singleton pregnancies. ART pregnancies in the current study include those achieved after in vitro fertilisation (IVF), intracytoplasmic sperm injection (ICSI), gamete intra-fallopian transfer (GIFT) and/or after frozen/thawed embryo transfer (FET) with autologous gametes. According to the WHO revised glossary on assisted reproductive terminology, ART does not include ovulation induction (OI) or intrauterine insemination (IUI). 15 Furthermore, studies including donor gametes or surrogacy cycles in the ART cohorts were also excluded to increase the homogeneity of the population studied and to allow a valid comparison with spontaneous or non-ART conceptions. The search terms included 'in vitro fertilisation', 'intracytoplasmic sperm injection', 'ART', 'placenta praevia', 'placenta accreta', 'placental abruption', 'umbilical cord anomalies' and derivatives of these terms. The full search strategy is available in Appendix S1. Additionally, the citation lists of all relevant publications and review articles were hand-searched. No language or date limitations were applied.
Selection of studies
Only comparative cohort studies were considered eligible as it is known that this study design provides the best source of observational evidence. 16 Case reports, case series and case control studies were excluded from this systematic review and meta-analysis as they are not considered as robust, as well as being associated with different biases that potentially lead to inflated effect sizes.
Data extraction
Data extraction was performed independently by two of the reviewers (B.G.V and C.A.V.). In case of missing information, the study authors were contacted to retrieve relevant data. Any disagreement between the two reviewers responsible for data extraction was solved by discussion. No core outcome sets or patient involvement was used for this meta-analysis.
Outcomes
As we anticipated some of the published studies to have produced adjusted odds ratios (aOR) through multivariable analyses, the outcome measure chosen for the current systematic review and meta-analysis was the odds ratio (OR) for each type of abnormal placentation in ART and non-ART pregnancies.
Quality assessment of eligible studies
The quality of the eligible studies was assessed with the use of a Newcastle-Ottawa scale 17 adapted for the specific research questions allowing up to 10 stars (Table S3) . Assessment of the quality of evidence has also been performed according to the GRADEPRO methodology. 18 
Quantitative data synthesis
The dichotomous data results for each of the eligible studies were expressed as an odds ratio or adjusted odds ratio with 95% confidence intervals (CI). The inverse variance method was used when the fixed or random effects method was applied. All results were combined for meta-analysis with REVMAN Software (Version 5.3 for PC, Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014). More specifically, as some studies offered both unadjusted and adjusted effect sizes, we pooled separately all unadjusted and adjusted odds ratios per comparison. Furthermore, to check the robustness of the results obtained we introduced a third combined analysis, where adjusted odds ratios from individual studies were combined with unadjusted odds ratios from the studies that did not offer adjusted effect sizes. This analysis was labelled 'best available', as it is using the best data that each study had to offer.
Study-to-study variation was assessed by using I 2 statistics (>40% indicating substantial heterogeneity). A fixed effects model was used where no substantial heterogeneity was present (I 2 = 0-40%), whereas in the presence of substantial heterogeneity (I 2 > 40%), a random effects model was applied, and attempts were made to explore the reasons for this heterogeneity. The presence of publication bias was assessed using the Egger's test. Statistical significance was set at a 5% P-value = 0.05. Considering the nature of data and in order to evaluate this research question holistically, the following pairwise comparisons were performed:
ART versus SC. ART versus non-ART. Unspecified; where it is not specified if the control groups only include spontaneous conceptions or if this cohort also includes pregnancies after ovulation induction (OI) and/or intrauterine insemination (IUI). frozen/thawed ET (FET)-ART versus SC. ART versus non-ART in subfertile patients (all patients were subfertile and the control group either conceived spontaneously or with OI and/or IUI).
Results
The flow chart of study identification is presented in Figure S1. Thirty-three studies (all written in English) were eligible, including 124 215 singleton ART pregnancies and 6 054 729 singleton non-ART pregnancies. Individual sample sizes ranged from 45 to 39 919 (median size 870 pregnancies) in the ART singleton pregnancy cohort and from 42 to 1 987 798 in the non-ART cohort (median size 4728 pregnancies). The study design and other methodological characteristics are presented in Table S1 . In 21 of the included studies, adjustments for potential confounders were performed through multivariable regression analyses and adjusted odds ratios for the outcome measures of interest were estimated (Table S2 ). Most of studies controlled for maternal age (n = 21) and/or parity (n = 20).
Quality assessment
Of the 33 studies included within the systematic review, 10 were graded as high quality, 18 as moderate quality and 5 as low quality (Table S3) . Furthermore, using the GRADE criteria, the evidence in half of the outcomes (6) was graded as low and in the remaining half (6) as very low (Tables S4-S7 ).
Meta-analysis
ART versus SC Placenta praevia: Twenty studies (14 moderate and 6 high quality) provided data for this comparison (74 311 ART versus 1 136 387 SC pregnancies). The unadjusted pooled OR was 4.43 (95% CI 3.32-5.92, P < 0.00001); random effects model, heterogeneity: P < 0.0001, I 2 = 82%; n = 6 studies. The adjusted pooled OR was 3.65 (95% CI 2.95-4.52, P < 0.00001; random effects model, heterogeneity: P < 0.00001, I 2 = 79%; n = 18 studies). The combined analysis ('best available') pooled OR was 3.76 (95% CI 3.09-4.59, P < 0.00001; random effects model, heterogeneity: P < 0.00001, I 2 = 79%, n = 20 studies) ( Figure 1A ). Egger's test did not detect the presence of publication bias (P = 0.952). Placental abruption: Eighteen studies (7 high and 11 moderate quality) provided data for this comparison (73 411 ART versus 1 085 532 SC pregnancies). The unadjusted pooled OR was 2.13 (95% CI 1.49-3.04, P < 0.0001; random effects model, heterogeneity: P = 0.04, I 2 = 57%; n = 6 studies). The adjusted pooled OR was 1.95, (95% CI 1.66-2.29, P < 0.00001; random effects model, heterogeneity P = 0.04, I 2 = 41%; n = 16 studies). The combined analysis ('best available') pooled OR was 1.87 (95% CI 1.70-2.06, P < 0.00001; fixed effects model, heterogeneity: P = 0.06, I 2 = 36%, n = 18 studies) ( Figure 1B ). Egger's test did not detect the presence of publication bias (P = 0.761). Morbidly adherent placenta: Two moderate quality studies provided data for this comparison (6229 ART versus 9457 SC pregnancies). The adjusted (and the 'best available') pooled OR was 2.27 (95% CI 1.79-2.87, P < 0.00001; fixed effects model, heterogeneity: P = 0.59, I 2 = 0%; n = 2 studies) ( Figure 1C ). The risk of publication bias could not be calculated due to the small number of studies. Abnormal cord insertion: Two moderate quality studies provided data for this comparison (1704 ART versus 5238 SC pregnancies). The adjusted (and the 'best available') pooled OR was 2.50 (95% CI 0.69-9.11, P = 0.16; random effects model, heterogeneity: P = 0.010, I 2 = 85%, n = 2 studies) ( Figure 1D ). The risk of publication bias could not be calculated due to the small number of studies.
ART versus non-ART (unspecified)
Placenta praevia: Eleven studies (2 high, 5 moderate and 4 low quality) provided data for this comparison (81 192 ART versus 4 402 216 non-ART pregnancies). The unadjusted pooled OR was 5.20, (95% CI: 3.74 to 7.24, P < 0.00001; random effects model, heterogeneity: P < 0.00001, I 2 = 89%; n = 7 studies). The adjusted pooled OR was 3.86, (95% CI: 2.63 to 5.67, P < 0.00001; random effects model, heterogeneity: P < 0.00001, I 2 = 93%; n = 5 studies). The combined analysis ("best available") pooled OR was 4.40, (95% CI: 3.42 to 5.67, P < 0.00001; random effects model, heterogeneity: P < 0.00001, I 2 = 91%, n = 11 studies) (Figure 2a ). Egger's test did not detect the presence of publication bias (P = 0.162). Placental abruption: Nine studies (1 high, 6 moderate and 2 low quality) provided data for this comparison (75 983 ART versus 3 743 054 non-ART pregnancies).
The unadjusted pooled OR was 2.22, (95% CI: 1.73 to 2.85, P < 0.00001; random effects model, heterogeneity: P = 0.06, I 2 = 52%; n = 6 studies). The adjusted pooled OR was 1.92, (95% CI: 1.73 to 2.15, P < 0.00001; fixed effects model, heterogeneity: P = 0.64, I 2 = 0%; n = 3 studies). The combined analysis ("best available") pooled OR was 2.12, (95% CI: 1.82 to 2.47, P < 0.00001; random effects model, heterogeneity: P = 0.07, I 2 = 45%, n = 9 studies) (Figure 2b) . Egger's test did not detect the presence of publication bias (P = 0.616). Abnormal cord insertion: Two moderate quality studies provided data for this comparison (10 258 ART versus 613 320 non-ART pregnancies). The unadjusted OR was 1.79, (95% CI: 1.69 to 1.90, P < 0.00001; n = 1 study). The adjusted pooled OR was 1.62, (95% CI: 1.53 to 1.72, P < 0.00001; fixed effects model, heterogeneity: P = 0.20, I 2 = 40%; n = 2 studies). The combined analysis ("best available") pooled OR was 1.62, (95% CI: 1.53 to 1.72, P < 0.00001; fixed effects model, heterogeneity: P = 0.20, I 2 = 40%, n = 2 studies) (Figure 2c) . The risk of publication bias could not be calculated due to the small number of studies. 
Frozen/thawed ET (FET)-ART versus SC
Placenta praevia: Two moderate quality studies provided data for this comparison (4178 FET-ART versus 603 157 SC pregnancies). The unadjusted pooled OR was 3.32 (95% CI 1.62-6.79, P = 0.001; random effects model, heterogeneity: P = 0.06, I 2 = 72%; n = 2 studies) The adjusted OR was 1.22 (95% CI 0.73-2.04, P = 0.45; n = 1 study). The combined analysis ('best available') pooled OR was 2.42 (95% CI 0.63-9.30, P = 0.20; random effects model, heterogeneity: P = 0.0004, I 2 = 92%, n = 2 studies) ( Figure 3A ). The risk of publication bias could not be calculated due to the small number of studies. Placental abruption: Two moderate quality studies provided data for this comparison (4178 FET-ART versus 603 157 SC pregnancies). The unadjusted OR was 1.34 (95% CI 0.82-2.20, P = 0.25; fixed effects model, heterogeneity: P = 0.50, I 2 = 0%; n = 2 studies) The adjusted OR was 1.21 (95% CI 0.69-2.12, P = 0.51; n = 1 study). The combined analysis ('best available') pooled OR was 1.15 (95% CI 0.69-1.91 P = 0.58; fixed effects model, heterogeneity: P = 0.69, I 2 = 0%, n = 2 studies) ( Figure 3B ). The risk of publication bias could not be calculated due to the small number of studies. Abnormal cord insertion: One high quality study provided data for this comparison (157 FET-ART versus 1453 SC pregnancies). The unadjusted OR was 2.31 (95% CI 1.51-3.53, P = 0.0001). The adjusted OR was 1.72 (95% CI 1.08-2.72, P = 0.02).
ART versus non-ART in the subfertile patient
Placenta praevia: Eight studies (three high, four moderate and one low quality) provided data for this comparison (19 865 ART versus 16 523 non-ART pregnancies). 
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The unadjusted pooled OR was 2.49 (95% CI 1.77-3.49, P < 0.00001; random effects model, heterogeneity: P = 0.010, I 2 = 67%; n = 6 studies). The adjusted OR was 2.33 (95% CI 1.94-2.79, P < 0.00001; fixed effects model, heterogeneity: P = 0.52, I 2 = 0%; n = 5 studies). The combined analysis ('best available') pooled OR was 2.51 (95% CI 2.12-2.98, P < 0.00001; fixed effects model, heterogeneity: P = 0.13, I 2 = 37%, n = 8 studies) ( Figure 4A ). Egger's test did not detect the presence of publication bias (P = 0.137). Placental abruption: Eight studies (three high, four moderate and one low quality) provided data for this comparison (20 680 ART versus 17 705 non-ART pregnancies). The unadjusted pooled OR was 1.70 (95% Figure 4 . Pooled odds ratio for (A) placenta praevia and (B) placental abruption, between singleton pregnancies after assisted reproductive technology (ART) versus singleton pregnancies after non-ART cycles in subfertile patients when the best available data were combined. CI 1.22-2.35, P = 0.002; random effects model, heterogeneity: P = 0.11, I 2 = 44%; n = 6 studies). The adjusted OR was 1.57 (95% CI 1.26-1.95, P < 0.0001; fixed effects model, heterogeneity: P = 0.75, I 2 = 0%; n = 3 studies). The combined analysis ('best available') pooled OR was 1.61 (95% CI 1.33-1.95, P < 0.00001; fixed effect model, heterogeneity: P = 0.35, I 2 = 10%, n = 8 studies) ( Figure 4B ). Egger's test did not detect the presence of publication bias (P = 0.545).
Discussion
Main findings
The results of this systematic review and meta-analysis suggest that singleton pregnancies conceived with the use of ART are associated with a significantly higher risk of placental anomalies compared with non-ART singleton pregnancies. The risk of placenta praevia was higher in all ART cohorts (although not statistically significant regarding FET-ART versus SC comparison) when compared with all non-ART cohorts. Similarly, this was also the case with morbidly adherent placenta, although the only available studies used spontaneously conceived pregnancies as controls. The risk of placental abruption was also higher in ART singleton pregnancies than in singleton pregnancies after spontaneous and non-ART modes of conception (unspecified and in subfertile patients), but no association was detected between FET-ART versus SC. The risk of cord insertion anomalies was higher in ART singleton pregnancies (including FET versus SC) than in non-ART pregnancies (unspecified). The same was suggested by the effect size of the comparison between ART and spontaneously conceived singleton pregnancies; however, that result was not significant.
There have been a number of meta-analyses conducted in the past that have evaluated the association of ART singleton pregnancies with adverse pregnancy outcomes. When considering placental anomalies, these studies have only evaluated placenta praevia and placental abruption. 4, [19] [20] [21] [22] The results of most of these meta-analyses agree with the findings of the present systematic review and meta-analysis and show a higher risk of placenta praevia 4, 20, 22 and placental abruption 4, 22 in ART singleton pregnancies than in spontaneously conceived singleton pregnancies.
Strengths and limitations
As compared to previously published meta-analysis, the current meta-analysis evaluates the risk of placental anomalies in a more holistic and comprehensive way by assessing the risk of morbidly adherent placenta and cord insertion anomalies, which can also cause catastrophic perinatal and obstetrical outcomes. Furthermore, the present meta-analysis is more comprehensive as it is more up to date, includes more studies and substantially increases the total sample size. When comparing the sample size of the current meta-analysis to the most recent published meta-analysis by Qin et al. 4 , the sample size has more than doubled and allows for a more precise estimation of the effect sizes.
This systematic review and meta-analysis also has some limitations. First, it is based on observational studies, some of which did not adjust for the important confounders and hence the presence of bias cannot be excluded. However, the additional analysis of studies that controlled for all identified confounders in their respective populations did not materially change the results. Detailed definitions of the outcomes of interest were not reported in the majority of the studies and hence an analysis by severity or subtype of placentation anomaly could not be performed. Also, for some of the comparisons only two studies were available, which renders the assessment of between-study heterogeneity and publication bias problematic. This potential heterogeneity in the eligible studies should be taken into account when interpreting the results of this systematic review. Finally, it should be noted that, using GRADE criteria, the quality of the evidence for the major outcomes analysed in this systematic review was considered to be very low or low.
Interpretation
The underlying mechanisms involved in the association of placental anomalies in ART singleton pregnancies are not well understood. Previous studies suggest that subfertility plays a role in abnormal placentation in singleton pregnancies. 3, 23, 24 In an attempt to control for the effect of subfertility in this meta-analysis, the risk of abnormal placentation was also evaluated in ART singleton pregnancies and in non-ART singleton pregnancies in subfertile patients only. The effect size and its direction were similar to that of the comparison between ART singleton pregnancies and non-ART singleton pregnancies in an unspecified population. The presence of this association clearly challenges the concept of subfertility being the only underlying reason. However, it should be stressed that the effect sizes when we compared ART with non-ART in subfertile patients appeared lower than to those present in the comparison between ART and SC, potentially suggesting the presence of a contribution of subfertility. At the same time, when interpreting this evidence, one should take into account that subfertile women who conceived after ART probably failed to conceive through non-ART processes, which means they may have had a more severe form of subfertility (time to conceive, uterine surgery, previous caesarean sections and pelvic inflammatory disease, etc.).
Another theory that has been suggested recently is the effect of supraphysiological steroid levels achieved during controlled ovarian stimulation and their effects on placentation. 25, 26 This is why in this meta-analysis, risks of abnormal placentation were compared between singleton pregnancies after FET-ART and singleton pregnancies after SC. Unfortunately, only two studies offered data for this comparison; although not statistically significant, a higher risk of placenta praevia was observed in FET-ART as compared with singleton pregnancies after SC. This suggests that the abnormal hormone milieu during ovarian stimulation for ART might not be the only contributing factor to the association observed between placental anomalies and ART and that the ART process, such as the embryo culture medium and embryo transfer process per se, might also be implicated in this association. Furthermore, it should be taken into consideration that the control group for this comparison was spontaneously conceived pregnancies from apparently fertile women and, as has been discussed previously, subfertility may also play a role in abnormal placentation. Therefore, this meta-analysis indicates a potential contributing role for subfertility, the endocrinological milieu and the ART process in the observed association between ART and placental anomalies.
Implications for clinical practice
The results of this systematic review, which are based on observation studies of low to moderate quality, suggest that ART has significant implications for obstetric and perinatal outcomes of singleton pregnancies compared with non-ART pregnancies. Clinicians should be aware of the increased risk of placental anomalies with singleton pregnancies and be alert for the presence of placenta praevia, placental abruption, morbidly adherent placenta and abnormal cord insertions. Patients who present to clinics for assisted reproduction treatment should be informed of potential risks of ART even with singleton pregnancies. The absolute risk increase for the different outcomes of this meta-analysis is presented in Tables S4-S7 .
Implications for future research
This systematic review and meta-analyses identifies the gaps in knowledge when evaluating the current research question. More specifically, it outlines that frequently in the literature, a large number of studies have not adjusted for patient characteristics that may be confounding the associations evaluated, and highlights the need for a better design of future studies. For example, a conscientious effort should be made to include more information on background medical history and on laboratory methods used during ART in order to identify contributing factors for the observed differences (such as type of infertility, estrogen and progesterone levels in late follicular phase, embryo culture media and cryopreservation protocols). Apparently, further research in this specific field is urgently needed.
Conclusion
This systematic review and meta-analysis has demonstrated that ART is associated with an overall increased risk of placental anomalies in singleton pregnancies compared with non-ART singleton pregnancies. The present study also provides indirect evidence that the ART process might be a contributing factor in this association. Further welldesigned and high-quality studies are warranted to confirm this finding and to elucidate its underlying pathophysiological mechanisms.
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